Evidence map›Paper›PMID 32815035›Full record

ArticleVirchows Archiv : an international journal of pathology2021

Nuclear expression of MDM2 in hibernoma: a potential diagnostic pitfall.

Yojiro Tsuda, Atsuji Matsuyama, Kosuke Makihara, Koichi Higaki, Toru Motoi, Tomotake Okuma, Masanori Hisaoka

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Molecular testing of soft tissue tumors.Diagnostic cytopathology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yojiro TsudaDepartment of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-Ku, Kitakyushu, 807-8555, Japan. yojiro-t@med.uoeh-u.ac.jp.ORCID http://orcid.org/0000-0002-4136-2601
Atsuji MatsuyamaDepartment of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-Ku, Kitakyushu, 807-8555, Japan.
Kosuke MakiharaDepartment of Surgical Pathology, Kyushu Rosai Hospital, Kitakyushu, 800-0296, Japan.
Koichi HigakiDivision of Pathology, St Mary Hospital, Kurume, 830-8543, Japan.
Toru MotoiDepartment of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, 113-8677, Japan.
Tomotake OkumaDepartment of Orthopedic Surgery and Musculoskeletal Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, 113-8677, Japan.
Masanori HisaokaDepartment of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-Ku, Kitakyushu, 807-8555, Japan.
University of Occupational and Environmental Health Japan · JPTokyo Metropolitan Komagome Hospital · JPKyushu Rosai Hospital · JPSt Mary's Hospital · JP

Funding

Japan Society for the Promotion of Science JP18K07704
6 · The paper itself

Abstract

Hibernoma is a rare benign adipocytic tumor composed of a proliferation of brown and white fat cells varying in their proportions. The tumor may also contain fat cells resembling lipoblasts, which makes it difficult to distinguish it from atypical lipomatous tumor/well differentiated liposarcoma (ALT/WDLS). Although nuclear expressions of murine double minute 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) are widely used as immunohistochemical surrogate markers for ALT/WDLS, the utility of these proteins in distinguishing between hibernoma and ALT/WDLS still remains to be elucidated. We evaluated immunohistochemical expressions of MDM2 and CDK4 in 10 hibernomas expressing uncoupling protein-1 (UCP-1), a mitochondrial protein transporter consistently expressed in brown fat cells, and lacking MDM2 gene amplification, which was analyzed by fluorescence in situ hybridization (FISH). In contrast to the data previously obtained, nuclear expression of MDM2 was observed in 100% (10/10 cases) of the hibernomas irrespective of the proportion of brown fat cells, whereas no cases were positive for CDK4. The tumors also showed almost concurrent expression of p53 (in 9/10 cases) and ubiquitin-specific-processing protease 7 (USP7) (in 10/10 cases), which deubiquitinates and stabilizes MDM2, potentially resulting in its nuclear expression without MDM2 gene amplification. MDM2 expression may thus be a diagnostic pitfall for hibernoma particularly in differentiating it from ALT/WDLS.

Indexed as

AdipocytesAdultAgedBiomarkers, TumorCell NucleusCyclin-Dependent Kinase 4Diagnosis, DifferentialFemaleHumansImmunohistochemistryIn Situ Hybridization, FluorescenceLipomaMaleMiddle AgedPredictive Value of TestsProto-Oncogene Proteins c-mdm2Biomarkers, TumorCDK4 protein, humanCyclin-Dependent Kinase 4MDM2 protein, humanProto-Oncogene Proteins c-mdm2TP53 protein, humanTumor Suppressor Protein p53Ubiquitin-Specific Peptidase 7UCP1 protein, humanUncoupling Protein 1USP7 protein, humanAtypical lipomatous tumor/well differentiated liposarcomaFISHHibernomaImmunohistochemical pitfallsMDM2

Identifiers

PMID32815035
OpenAlexW3080370496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.